| Hepatic insulin resistance, metabolic syndrome and cardiovascular disease R Meshkani, K Adeli Clinical biochemistry 42 (13-14), 1331-1346, 2009 | 595 | 2009 |
| Molecular and cellular mechanisms linking inflammation to insulin resistance and β-cell dysfunction H Khodabandehloo, S Gorgani-Firuzjaee, G Panahi, R Meshkani Translational Research 167 (1), 228-256, 2016 | 310 | 2016 |
| Tissue resident macrophages: Key players in the pathogenesis of type 2 diabetes and its complications R Meshkani, S Vakili Clinica chimica acta 462, 77-89, 2016 | 158 | 2016 |
| The effects of resveratrol on markers of oxidative stress in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trial SS Seyyedebrahimi, H Khodabandehloo, E Nasli Esfahani, R Meshkani Acta diabetologica 55, 341-353, 2018 | 155 | 2018 |
| Resveratrol alleviates non-alcoholic fatty liver disease through epigenetic modification of the Nrf2 signaling pathway H Hosseini, M Teimouri, M Shabani, M Koushki, RB Khorzoughi, ... The international journal of biochemistry & cell biology 119, 105667, 2020 | 108 | 2020 |
| High glucose induces inflammatory responses in HepG2 cells via the oxidative stress-mediated activation of NF-κB, and MAPK pathways in HepG2 cells G Panahi, P Pasalar, M Zare, R Rizzuto, R Meshkani Archives of physiology and biochemistry 124 (5), 468-474, 2018 | 87 | 2018 |
| Resveratrol ameliorates palmitate‐induced inflammation in skeletal muscle cells by attenuating oxidative stress and JNK/NF‐κB pathway in a SIRT1‐independent mechanism A Sadeghi, SS Seyyed Ebrahimi, A Golestani, R Meshkani Journal of cellular biochemistry 118 (9), 2654-2663, 2017 | 85 | 2017 |
| The relationship between uric acid and metabolic syndrome in normal glucose tolerance and normal fasting glucose subjects R Meshkani, M Zargari, B Larijani Acta diabetologica 48, 79-88, 2011 | 84 | 2011 |
| Effect of resveratrol supplementation on inflammatory markers: a systematic review and meta-analysis of randomized controlled trials M Koushki, NA Dashatan, R Meshkani Clinical therapeutics 40 (7), 1180-1192. e5, 2018 | 83 | 2018 |
| Prevalence of metabolic syndrome among Iranian population: a systematic review and meta-analysis S Dalvand, SH Niksima, R Meshkani, RG Gheshlagh, S Sadegh-Nejadi, ... Iranian journal of public health 46 (4), 456, 2017 | 79 | 2017 |
| Aerobic endurance training improves nonalcoholic fatty liver disease (NAFLD) features via miR-33 dependent autophagy induction in high fat diet fed mice P Ghareghani, M Shanaki, S Ahmadi, AR Khoshdel, N Rezvan, ... Obesity research & clinical practice 12 (1), 80-89, 2018 | 78 | 2018 |
| Resveratrol alleviates obesity-induced skeletal muscle inflammation via decreasing M1 macrophage polarization and increasing the regulatory T cell population M Shabani, A Sadeghi, H Hosseini, M Teimouri, R Babaei Khorzoughi, ... Scientific reports 10 (1), 3791, 2020 | 76 | 2020 |
| Genetic and pharmacological targeting of A2a receptor improves function of anti-mesothelin CAR T cells E Masoumi, L Jafarzadeh, HR Mirzaei, K Alishah, K Fallah-Mehrjardi, ... Journal of Experimental & Clinical Cancer Research 39, 1-12, 2020 | 66 | 2020 |
| Curcumin ameliorates palmitate-induced inflammation in skeletal muscle cells by regulating JNK/NF-kB pathway and ROS production A Sadeghi, A Rostamirad, S Seyyedebrahimi, R Meshkani Inflammopharmacology 26, 1265-1272, 2018 | 66 | 2018 |
| Impaired HDL cholesterol efflux capacity in patients with non-alcoholic fatty liver disease is associated with subclinical atherosclerosis R Fadaei, H Poustchi, R Meshkani, N Moradi, T Golmohammadi, S Merat Scientific Reports 8 (1), 11691, 2018 | 59 | 2018 |
| The relationship between homeostasis model assessment and cardiovascular risk factors in Iranian subjects with normal fasting glucose and normal glucose tolerance R Meshkani, M Taghikhani, B Larijani, S Khatami, E Khoshbin, K Adeli Clinica chimica acta 371 (1-2), 169-175, 2006 | 56 | 2006 |
| Activation of Nrf2-antioxidant response element mediated glutamate cysteine ligase expression in hepatoma cell line by homocysteine M Mani, S Khaghani, TG Mohammadi, Z Zamani, K Azadmanesh, ... Hepatitis monthly 13 (5), 2013 | 54 | 2013 |
| The influence of psychological stress on the initiation and progression of diabetes and cancer R Afrisham, M Paknejad, O Soliemanifar, S Sadegh-Nejadi, R Meshkani, ... International journal of endocrinology and metabolism 17 (2), 2019 | 52 | 2019 |
| Decreased serum microRNA-21 level is associated with obesity in healthy and type 2 diabetic subjects S Ghorbani, R Mahdavi, B Alipoor, G Panahi, E Nasli Esfahani, F Razi, ... Archives of physiology and biochemistry 124 (4), 300-305, 2018 | 51 | 2018 |
| SH2 domain-containing inositol 5-phosphatase (SHIP2) inhibition ameliorates high glucose-induced de-novo lipogenesis and VLDL production through regulating AMPK/mTOR/SREBP1 … S Gorgani-Firuzjaee, R Meshkani Free radical biology and medicine 89, 679-689, 2015 | 51 | 2015 |
Ghodratollah panahiTehran university of medical sciencesVerified email at sina.tums.ac.ir
